![Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial | Addiction Science & Clinical Practice | Full Text Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial | Addiction Science & Clinical Practice | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13722-021-00220-2/MediaObjects/13722_2021_220_Fig1_HTML.png)
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial | Addiction Science & Clinical Practice | Full Text
![Beyond the Basics: How Should We Manage Acute Pain in Hospitalized Patients with OUD? - The Hospitalist Beyond the Basics: How Should We Manage Acute Pain in Hospitalized Patients with OUD? - The Hospitalist](https://www.the-hospitalist.org/wp-content/uploads/2022/10/Table1_WEB.jpg)
Beyond the Basics: How Should We Manage Acute Pain in Hospitalized Patients with OUD? - The Hospitalist
![Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder | Psychiatrist.com Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2022/12/21cr03150T1-scaled.gif)
Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder | Psychiatrist.com
![Full article: Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future Full article: Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future](https://www.tandfonline.com/cms/asset/51b12b66-8dbf-46bc-884e-d8bb68527bf9/ucjp_a_1795634_f0001_oc.jpg)
Full article: Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future
![Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel | Regional Anesthesia & Pain Medicine Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel | Regional Anesthesia & Pain Medicine](https://rapm.bmj.com/content/rapm/46/10/840/F2.large.jpg)
Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel | Regional Anesthesia & Pain Medicine
![Full article: Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future Full article: Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future](https://www.tandfonline.com/cms/asset/57385957-9c6c-408b-98f1-c9ab2bc3e385/ucjp_a_1795634_f0002_oc.jpg)
Full article: Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future
![Office-based Opioid Treatment with Buprenorphine: Insights from the Massachusetts Model – Recovery Research Institute Office-based Opioid Treatment with Buprenorphine: Insights from the Massachusetts Model – Recovery Research Institute](https://www.recoveryanswers.org/assets/Patient-Flow-of-Massachusetts-Model-Barriers-to-Prescribing-Buprenorphine-Suboxone-Addiction-treatment-Office-based-Opioid-Treatment-with-Buprenorphine-Insights-from-the-Massachusetts-Model-LaBelle-Table-1.jpg)
Office-based Opioid Treatment with Buprenorphine: Insights from the Massachusetts Model – Recovery Research Institute
![Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel | Regional Anesthesia & Pain Medicine Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel | Regional Anesthesia & Pain Medicine](https://rapm.bmj.com/content/rapm/46/10/840/F1.large.jpg)
Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel | Regional Anesthesia & Pain Medicine
![A quick-reference guide for prescribing buprenorphine/naloxone (Suboxone) in the outpatient setting | British Columbia Medical Journal A quick-reference guide for prescribing buprenorphine/naloxone (Suboxone) in the outpatient setting | British Columbia Medical Journal](https://bcmj.org/sites/default/files/public/BCMJ_Vol60_No8_Suboxone-figure-2.jpg)